+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Results of stereotactic guidance of breast excisional biopsy versus stereotactic core biopsy in occult breast lesions



Results of stereotactic guidance of breast excisional biopsy versus stereotactic core biopsy in occult breast lesions



Wiener Medizinische Wochenschrift 148(14): 316-320



Interventional procedures, whether markings or core biopsies, are very important for clarifying non-palpable breast lesions. Both at present as well as in future--in the age of breast screening--such methods must be used more and more. Although breast screening is not carried out on an organized basis in our country, it is gaining importance. Currently there is a covert screening in progress and women are availing this facility to an increasing extent. Various organisations including the press and audio-visual media have arisen the interest of the population. An increase in diagnostic studies is being flanked by an increase in surgical activity. As a result, on the one hand a larger number of small carcinomas as well as benign lesions are being operated. This has brought the cost-bearers, i.e. all of us, to the limits of what can be done. Surgery costs money. One solution to the problem is preoperative marking which is used in all patients suspected of carcinoma, and the other is core biopsy which is used in lesions that appear benign on X-rays. Radiologically benign lesions are not histological diagnoses. Although a well trained radiologist will make the correct diagnosis in 95 to 98% of cases, the possibility of error is still 2 to 50%. In the light of this knowledge, it would appear logical to operate all apparently benign lesions. However, a more intensive use of bioptic procedures is a solution to this problem. To compare costs: Surgery for clarification of a lesion involves a hospital stay of about 3 days while bioptic studies can be carried out on an outpatient basis. Besides, surgery costs 2 to 3 times more than bioptic studies, depending on the hospital and the bioptic material used. A core biopsy needle costs about two-thirds the price of a rotating cannula. However, it should be emphasized that core biopsy is not a method of treatment and will never be one. It should remain a diagnostic procedure, although small lesions may well be aspirated by this method. The ABBI systems is intended to be a therapeutic method. At present, no final statement can be made about the utility of this procedure.

(PDF emailed within 1 workday: $29.90)

Accession: 047258472

Download citation: RISBibTeXText

PMID: 9816641


Related references

Diagnosis of non-palpable lesions of the breast with stereotactic excisional biopsy with cannula. Advanced Breast Biopsy Instrumentation (ABBI) with fine diameter of 20 mm. La Radiologia Medica 95(5): 437-444, 1998

Cost analysis of stereotactic vacuum assisted core biopsy vs stereotactic large core excisional biopsy vs needle localization biopsy by pathologic outcome. Breast Cancer Research & Treatment 64(1): 57, 2000

Stereotactic core breast biopsy versus needle localization breast biopsy - the effect of initial diagnostic modality on surgical therapy in patients with breast cancer. Minimally Invasive Therapy & Allied Technologies 6(3): 225-227, 1997

Stereotactic biopsy for non-palpable breast lesions: evaluation and choice of minimal invasive and excisional biopsy. Zhonghua Wai Ke Za Zhi 44(19): 1322-1324, 2007

Stereotactic excisional breast biopsy utilizing the advanced breast biopsy instrumentation A new form of minimally invasive breast surgery. European Journal of Cancer 36(Suppl. 5): S62, 2000

Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy. British Journal of Cancer 90(2): 383-392, 26 January, 2004

Breast biopsies: stereotactic vacuum-assisted core biopsy and stereotactic surgical breast biopsy. Gynecologie, Obstetrique and Fertilite 31(3): 256-264, 2003

Stereotactic breast biopsy: comparison of vacuum punch biopsy versus high speed core biopsy. Wiener Medizinische Wochenschrift 148(14): 331-334, 1998

Stereotactic excisional nonpalpable breast lesions using the advanced breast biopsy instrumentation. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 29(2): 142-147, 2000

Different types of solid, non-palpable breast lesions Stereotactic core needle biopsy using add-on stereotactic device. European Journal of Cancer 38(Suppl. 3): S140, 2002

Stereotactic excisional breast biopsy performed by interventional radiologists using the advanced breast biopsy instrumentation system. British Journal of Radiology 71(850): 1003-1011, 1999

Breast stereotactic core biopsy washings: abundant cell samples from clinically occult lesions for flow cytometric DNA analysis. Investigative Radiology 33(1): 51-55, 1998

Experience of stereotactic breast biopsy using the vacuum-assisted core needle biopsy device and the advanced breast biopsy instrumentation system in Hong Kong women. Asian Journal of Surgery 28(1): 18-23, 2005

Stereotactic vacuum-assisted core biopsy results for non-palpable breast lesions. Asian Pacific Journal of Cancer Prevention 15(13): 5171-5174, 2015

Stereotactic core needle biopsy of mammographic breast lesions as a viable alternative to surgical biopsy. Annals of Surgical Oncology 1(5): 363-367, 1994